These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11876549)

  • 1. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis.
    Kuniyasu H; Oue N; Shigeishi H; Ito R; Kato Y; Yokozaki H; Yasui W
    J Exp Clin Cancer Res; 2001 Dec; 20(4):543-8. PubMed ID: 11876549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
    Nabi U; Nagi AH; Sami W
    J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas.
    Mitomi H; Mori A; Kanazawa H; Nishiyama Y; Ihara A; Otani Y; Sada M; Kobayashi K; Igarashi M
    Hepatogastroenterology; 2005; 52(65):1421-6. PubMed ID: 16201087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
    Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
    Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
    Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
    Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.
    Canna K; Hilmy M; McMillan DC; Smith GW; McKee RF; McArdle CS; McNicol AM
    Colorectal Dis; 2008 Sep; 10(7):663-7. PubMed ID: 18005189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
    Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
    Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer.
    Ishida H; Miwa H; Tatsuta M; Masutani S; Imamura H; Shimizu J; Ezumi K; Kato H; Kawasaki T; Furukawa H; Kawakami H
    Cancer Lett; 2004 Apr; 207(1):109-15. PubMed ID: 15050740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
    Oshima CT; Iriya K; Forones NM
    Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB; Wu AG; Chen YJ; Tang BH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Ki-67 labeling index in human colorectal cancer with microsatellite instability.
    Takagi S; Kumagai S; Kinouchi Y; Hiwatashi N; Nagashima F; Takahashi S; Shimosegawa T
    Anticancer Res; 2002; 22(6A):3241-4. PubMed ID: 12530070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.